Luca Dezzani, MD is a medical doctor with extensive healthcare experience as a physician in clinical practice and in the pharmaceutical industry. He practiced as a physician in Hematology and Internal Medicine before joining Novartis Oncology where he served in roles at national, regional, and global levels in Europe and North America. More recently, he built and led the US Oncology medical organization at Eisai. He has a strong expertise in oncology clinical development and medical affairs, and he is passionate about the application of technology to healthcare. Luca now leads the Immuno-Oncology Franchise within the US Oncology Organization at AstraZeneca.
New recommendations may provide reassurance for patients and their care teams, while uniquely positioning healthcare providers to help communicate this critical information to vulnerable populations.